These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19180747)

  • 21. [Innovations in ambulatory care: screening, treatment and iatrogenicity].
    Bodenmann P; Pasche O; Jaunin-Stalder N; Willi C; Pasche C; Ombelli J; Cornuz J
    Rev Med Suisse; 2008 Jan; 4(142):289-94. PubMed ID: 18383937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPI inhibitors.
    Edson DH
    Conn Med; 2008; 72(6):375. PubMed ID: 18610717
    [No Abstract]   [Full Text] [Related]  

  • 23. By the way, doctor. I heard that taking a proton-pump inhibitor could cause hip fractures. I've been taking 20 mg of Prilosec every day for a year. Should I be concerned?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Mar; 14(7):8. PubMed ID: 17396273
    [No Abstract]   [Full Text] [Related]  

  • 24. Hip fracture and proton pump inhibitor therapy: position statement.
    Moayyedi P;
    Can J Gastroenterol; 2008 Oct; 22(10):855-8. PubMed ID: 19009722
    [No Abstract]   [Full Text] [Related]  

  • 25. Unexpected consequences of proton pump inhibitor use.
    Altman KW; Radosevich JA
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):564-6. PubMed ID: 19861191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uses of proton pump inhibitors and serum potassium levels.
    Gau JT; Heh V; Acharya U; Yang YX; Kao TC
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):865-71. PubMed ID: 19557730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
    Dalton BR; Lye-Maccannell T; Henderson EA; Maccannell DR; Louie TJ
    Aliment Pharmacol Ther; 2009 Mar; 29(6):626-34. PubMed ID: 19183143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Safety of Proton Pump Inhibitors: Bone Fracture Risk as an Example.
    Sugiyama T
    Am J Gastroenterol; 2021 Jul; 116(7):1557. PubMed ID: 33491960
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: proton pump inhibitor use and bone fracture risk-a mechanistic point of view.
    Sugiyama T
    Aliment Pharmacol Ther; 2021 Mar; 53(5):671-672. PubMed ID: 33566413
    [No Abstract]   [Full Text] [Related]  

  • 30. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis.
    Pongprasobchai S; Kridkratoke S; Nopmaneejumruslers C
    J Med Assoc Thai; 2009 May; 92(5):632-7. PubMed ID: 19459523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stop the PPI express: they don't keep babies quiet!
    Putnam PE
    J Pediatr; 2009 Apr; 154(4):475-6. PubMed ID: 19324214
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term therapy with proton pump inhibitors is associated with decreased bone density.
    Bratanic A; Kokic S; Hozo I; Barisic I; Kokic V
    Med Hypotheses; 2009 May; 72(5):608-9. PubMed ID: 19217215
    [No Abstract]   [Full Text] [Related]  

  • 34. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitors may trigger vitiligo by rendering melanocytes prone to apoptosis.
    Namazi MR
    Br J Dermatol; 2008 Apr; 158(4):844-5. PubMed ID: 18205862
    [No Abstract]   [Full Text] [Related]  

  • 36. [Gastric polyposis due to treatment with proton pump inhibitors].
    Huguet JM; Ruiz L; Ortí E; Luján M; Sempere J; Medina E
    Gastroenterol Hepatol; 2009 Feb; 32(2):88-91. PubMed ID: 19231680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine.
    Namazi MR
    Lupus; 2009 Feb; 18(2):104-5. PubMed ID: 19151110
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: let's take a break from studying the PPI-fracture association.
    Targownik LE
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1543-1544. PubMed ID: 29878429
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic diarrhea responding to proton pump inhibitors: a clinical sign of Zollinger-Ellison syndrome.
    Zimmer V; Schilling MK; Buecker A; Lammert F; Raedle J
    Am J Med; 2009 Nov; 122(11):e9-e10. PubMed ID: 19854317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.